DMTC’s Medical Countermeasures Program is growing with Round 2 projects announced by the Minister for Defence Industry, the Hon Christopher Pyne MP.
Medical countermeasures (MCMs) are vaccines, therapeutics and/or diagnostics against chemical, biological and radiological threat, emerging infectious disease and pandemics.
The new projects follow on from the first round of DMTC’s MCM Program that has been underway for around 15 months.
With its priorities set by Defence, seed funding for the DMTC MCM program has been provided by CSIRO and the Defence Science & Technology Group through its Next Generation Technologies Fund (NGTF). The aim of the MCM program is to accelerate the advanced development and deployment of countermeasures, with technical expertise from industry and research partners.
Under DMTC’s proven co-investment model, funding provided by Government customer agencies is leveraged by contributions of cash and resources from industry and research partners.
The Minister’s press release is available here and more details will be available on our website as soon as contract negotiations and project agreements are complete.
DMTC has featured prominently in prestigious awards recognising success in naval and maritime innovation.
The Maritime Australia Industry Innovation Awards were presented by the Minister for Defence Industry, the Hon Christopher Pyne MP, on 4 October at the Pacific 2017 International Maritime Exposition in Sydney.
DMTC received a High Commendation for its leadership of a project to study Microbiological Corrosion on Australian naval vessels, and DMTC researcher Peter Kabakov was recognised with the prestigious Young Innovator scholarship prize.
Employed by the Australian Nuclear Science & Technology Organisation (ANSTO), Mr Kabakov has worked on a DMTC project involving research partners ANSTO and University of Wollongong and DMTC industry partner Thales Australia (Thales Underwater Systems) to establish an Australian production capability for single crystal, piezoelectric ceramics.
DMTC’s business model is firmly founded on a commitment to business excellence and improvement. This has recently been confirmed with DMTC achieving certification to the ISO 9001:2015 Quality Management Standard. This is an important (and independent) verification of our approach to the business of collaboration with our industry and research partners, and a great credit to the whole DMTC community and particularly the head office team.
DMTC chief executive Mark Hodge joined Defence Connect podcast host Phil Tarrant for a wide-ranging discussion on the Australian defence industry and the future of collaborative technology development. The pair discussed DMTC’s transition to a proven industrial capability partner for Defence, and the current portfolio of projects DMTC is taking on to further develop the technological capabilities of the Australian defence industry.
